Literature DB >> 22147001

Making investments in medical technology: time to get real about real options.

Philip D Dreyfuss1, Thomas G Roberts.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22147001      PMCID： PMC3248765          DOI： 10.1634/theoncologist.2011-0345

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  3 in total

1.  When to wait for more evidence? Real options analysis in proton therapy.

Authors:  Janneke P C Grutters; Keith R Abrams; Dirk de Ruysscher; Madelon Pijls-Johannesma; Hans J M Peters; Eric Beutner; Philippe Lambin; Manuela A Joore
Journal:  Oncologist       Date:  2011-12-06

2.  The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.

Authors:  Janneke P C Grutters; Madelon Pijls-Johannesma; Dirk De Ruysscher; Andrea Peeters; Stefan Reimoser; Johan L Severens; Philippe Lambin; Manuela A Joore
Journal:  Cancer Treat Rev       Date:  2010-03-29       Impact factor: 12.111

3.  Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis.

Authors:  Janneke P C Grutters; Alfons G H Kessels; Madelon Pijls-Johannesma; Dirk De Ruysscher; Manuela A Joore; Philippe Lambin
Journal:  Radiother Oncol       Date:  2009-09-03       Impact factor: 6.280
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.